Tempest Therapeutics (TPST) - News Mentions

Sign up to add (TPST) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 2 100%
Gilead Sciences
Gilead Sciences
GILD		 1 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 100%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Tempest Therapeutics, Inc. (NASDAQ:TPST) Sees Large Decrease in Short Interest
April 15
Tempest Therapeutics’ (TPST) “Neutral” Rating Reaffirmed at HC Wainwright
April 12
Scotiabank Reiterates Sector Perform Rating for Tempest Therapeutics (NASDAQ:TPST)
April 11
Research Analysts Issue Forecasts for TPST Q1 Earnings
March 31
FY2028 Earnings Estimate for TPST Issued By William Blair
March 30
Tempest Therapeutics (NASDAQ:TPST) Given New $7.00 Price Target at Scotiabank
March 29
HC Wainwright Lowers Tempest Therapeutics (NASDAQ:TPST) Price Target to $16.00
March 29
Tempest Therapeutics (TPST) to Release Earnings on Tuesday
March 15
FDA Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for the Treatment of Familial Adenomatous Polyposis (FAP)
March 13
Comparing Nkarta (NASDAQ:NKTX) & Tempest Therapeutics (NASDAQ:TPST)
February 28
XTX Topco Ltd Buys New Stake in Tempest Therapeutics, Inc. (NASDAQ:TPST)
December 23
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
April 10
Tempest Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value
April 9
Tempest Reports Year End 2024 Financial Results and Provides Business Update
March 27
Tempest Announces Amezalpat Poster Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
March 25
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 7

Month over Month

Est. daily news mentions.

Mar 2025 0
Feb 2025 0
Jan 2025 0
Dec 2024 0
Nov 2024 0

How often is Tempest Therapeutics mentioned in the news?

Tempest Therapeutics was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Tempest Therapeutics performing compared to its industry peers?

Tempest Therapeutics underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Tempest Therapeutics in the last month?

There has been no significant change in the number of news mentions for Tempest Therapeutics' compared to the last month.

Why is it important to track news mentions for Tempest Therapeutics?

By monitoring mentions in the news for Tempest Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Tempest Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on Tempest Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact